Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients

Last updated: October 30, 2023
Sponsor: Centre Hospitalier Intercommunal Creteil
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hepatitis

Liver Disorders

Treatment

Hepatitis C testing

Clinical Study ID

NCT04405024
HOSPI-VHC
2019-A03309-48
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The Ministry of Health has set the target of eradicating hepatitis C (HCV) in France by 2025.

The goal is to validate the feasibility and value of conducting routine HCV screening in hospitalized patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient over 18 years of age
  • Hospitalized during the study period
  • Non-opposition for participation in the Protocol

Exclusion

Exclusion Criteria:

  • Patients under 18 years of age
  • Outpatient, long-stay, maternity and intensive care inpatients
  • Patients refusing blood collection
  • Patient may not understand the information sheet
  • Patient under guardianship

Study Design

Total Participants: 2500
Treatment Group(s): 1
Primary Treatment: Hepatitis C testing
Phase:
Study Start date:
September 21, 2020
Estimated Completion Date:
August 21, 2024

Study Description

The number of undetected HCV-infected persons has been extrapolated to 75,000 according to the results of a 2014 study. Screening efforts have been set up in groups of people said to be at high viral risk: drug users, prisoners, precarious persons or migrants from highly endemic countries. Nevertheless, the concept of universal screening has not yet been adopted by the guardians and the Ministry.

It is in this context that "hepatitis free hospital" projects have been carried out in several French cities such as Nice, Nancy and Marseille.

The aim of the HOSPI-VHC study is to evaluate the feasibility and efficiency of systematic HCV screening in all medical and surgical departments of 4 National Association of Hepato-Gastroenterologists of General Hospitals (ANGH) hospitals. This pilot project is part of a public health screening program. It will evaluate the interest and usefulness of implementing universal screening in hospitalized patients without taking into account the existence of viral risk factors. This study will also make it possible to evaluate the implementation of a dedicated care pathway: number of patients screened, number of patients referred for consultation and number of patients accepting the consultation.

Connect with a study center

  • CHI Créteil

    Créteil, 94000
    France

    Active - Recruiting

  • Grand Hôpital de l'Est Francilien - Site de Marne-la-Vallée

    Jossigny,
    France

    Active - Recruiting

  • CH Meaux

    Meaux,
    France

    Active - Recruiting

  • CHIV

    Villeneuve-Saint-Georges,
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.